1. Levetiracetam for seizure prevention in brain tumor patients: a systematic review

   • Ziad Ghantous Nasr
   • Bridget Paravattil
   • Kyle John Wilby

   Topic Review 11 May 2016 Pages: 1 - 13

   

2. Risk and survival outcomes of radiation-induced CNS tumors

   • Jessica W. Lee
   • A. Gabriella Wernicke

   Topic Review 21 May 2016 Pages: 15 - 22

3. Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion

   • Ye Gu
   • Xinyao Zhou
   • Xiaobiao Zhang

   Laboratory Investigation 11 May 2016 Pages: 23 - 31

   

4. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth

   • G. Acker
   • A. Palumbo
   • M. Czabanka

   Laboratory Investigation 17 May 2016 Pages: 33 - 38

   

5. Quercetin blocks t-AUCB-induced autophagy by Hsp27 and Atg7 inhibition in glioblastoma cells in vitro

   • Junyang Li
   • Chao Tang
   • Youwu Fan

   Laboratory Investigation 12 May 2016 Pages: 39 - 45

   

6. An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth

   • Nicolas-Xavier Bonne
   • Jérémie Vitte
   • Marco Giovannini

   Laboratory Investigation 13 May 2016 Pages: 47 - 56

   

7. Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats

   • I. A. Netland
   • H. E. Førde
   • D. Goplen

   Laboratory Investigation Open access 09 June 2016 Pages: 57 - 66

   

8. Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation

   • Magdalena Ciezka
   • Milena Acosta
   • Carles Arús

   Laboratory Investigation 21 June 2016 Pages: 67 - 76

   

9. Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease

   • Eugene L. Scharf
   • Curtis A. Hanson
   • B. Mark Keegan

   Clinical Study 09 May 2016 Pages: 77 - 83

   

10. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series

    • J. Castelli
    • L. Feuvret
    • G. Noel

    Clinical Study 11 May 2016 Pages: 85 - 92

    

11. Prognostic factors in recurrent glioblastoma patients treated with bevacizumab

    • Christina Schaub
    • Julia Tichy
    • Oliver Bähr

    Clinical Study 18 May 2016 Pages: 93 - 100

    

12. Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma

    • Yasuo Iwadate
    • Tomoo Matsutani
    • Naokatsu Saeki

    Clinical Study 18 May 2016 Pages: 101 - 107

    

13. Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma

    • Fernando Carceller
    • Lucy A. Fowkes
    • Stergios Zacharoulis

    Clinical Study 14 May 2016 Pages: 109 - 121

    

14. Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis

    • Mathieu Boone
    • Martine Roussel
    • Olivier Godefroy

    Clinical Study 30 May 2016 Pages: 123 - 130

    

15. Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

    • Regina I. Jakacki
    • Margaret A. Foley
    • Stan C. Gill

    Clinical Study 10 June 2016 Pages: 131 - 138

    

16. A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas

    • Jeffrey J. Raizer
    • James P. Chandler
    • Markus Bredel

    Clinical Study 14 June 2016 Pages: 139 - 146

    

17. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma

    • Jacob J. Mandel
    • David Cachia
    • John F. de Groot

    Clinical Study 07 June 2016 Pages: 147 - 154

    

18. Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of life

    • K. Baumstarck
    • T. Leroy
    • P. Auquier

    Clinical Study 14 June 2016 Pages: 155 - 164

    

19. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma

    • Felicitas Strehlow
    • Sandra Bauer
    • Stephan Kreher

    Clinical Study 13 June 2016 Pages: 165 - 171

    

20. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1

    • Michael J. Wan
    • Nicole J. Ullrich
    • Gena Heidary

    Clinical Study 16 June 2016 Pages: 173 - 178

    

21. Antidepressant use and risk of central nervous system metastasis

    • Megan M. Herr
    • Nimish A. Mohile
    • David Q. Rich

    Clinical Study 11 June 2016 Pages: 179 - 187

22. Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?

    • André O. von Bueren
    • Clemens Seidel
    • Carsten Friedrich

    Letter to the Editor 09 June 2016 Pages: 189 - 191

    

23. First report on spinal metastasis in childhood-onset craniopharyngioma

    • Anika Hoffmann
    • Angela Brentrup
    • Hermann L. Müller

    Letter to the Editor 09 June 2016 Pages: 193 - 194